Clinical Trial Update: Acthar Gel in Participants With Pulmonary Sarcoidosis [Phase 4]

View source ↗

Summary

Phase 4 trial update for Acthar Gel in participants with pulmonary sarcoidosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Sarcoidosis
• Sarcoidosis

Drugs mentioned

• Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: Mallinckrodt | Conditions: Sarcoidosis, Pulmonary | Phase 4 | Status: COMPLETED | Results posted: 2023-02-27